Samuel D. Waksal
 |
This biographical article needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful. (January 2010) |
| Samuel D. Waksal | |
|---|---|
| Born | September 8, 1947 Paris, France |
| Charge(s) | fraud, conspiracy, perjury |
| Penalty | 87 months imprisonment |
Samuel D. Waksal (born 8 September 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems, which developed the drug Erbitux (cetuximab). In the course of an insider trading scandal, he was convicted of several white collar crimes, served time in federal prison, and has now been released.
Contents |
[edit] Education
Waksal earned a bachelor's degree in 1969 and a doctorate in immunobiology in 1974, both from The Ohio State University.
[edit] Criminal activity and conviction
He was arrested June 12, 2002 on insider trading charges. On October 15, he pleaded guilty to charges of securities fraud, bank fraud, obstruction of justice, and perjury.
On March 3, 2003 he pleaded guilty to charges of conspiracy and wire fraud for avoiding $1.2 million in sales taxes on $15 million in artwork. The art included works by Mark Rothko, Richard Serra, Roy Lichtenstein, and Willem de Kooning, purchased between June 2000 and October 2001. He did not pay the necessary taxes at the time of purchase, but did pay the taxes in fall 2002.
On June 10, 2003, Waksal was sentenced to seven years and three months in prison and ordered to pay more than $4 million in fines and back taxes, all the maximum punishments allowable under law. As a federal inmate, Waksal was not eligible for parole.[citation needed] Waksal wanted to go to Federal Prison Camp, Eglin, but instead he went to Federal Correctional Institution, Schuylkill.[1] He was serving time in the Federal Correctional Institution, Otisville in New York state.[citation needed] Waksal, Federal Bureau of Prisons (BOP) # 53803-054, was released from BOP custody on February 9, 2009.[2]
[edit] Notes
On Jan 23, 2011, Mr. Waksal was interviewed by Maria Bartiromo on Wall Street Week. At that time, he declared his intention to start a new biotech company. He is currently the chairman and CEO of Kadmon Pharmaceuticals in New York City.
- ^ Rose, Lacey. "Best Places to Go to Prison." Forbes. April 17, 2006. Retrieved on January 10, 2010.
- ^ "Samuel Waksal." Federal Bureau of Prisons. Retrieved on January 10, 2010.
[edit] External links
- ImClone Founder Pleads Guilty to Avoiding Sales Taxes, The New York Times, March 3, 2003
- ImClone founder Waksal sentenced to 7 years in prison, San Francisco Chronicle, June 10, 2003
- Sam Waksal: I Was Arrogant, CBS News, October 2, 2003
- Free Samuel Waksal argues that Waksal's insider trading should not be considered a crime and that he does not belong in jail
- Sam Waksal Political Contributions
- New York Post on his release from jail
- 1947 births
- Living people
- People from Paris
- American businesspeople
- American immunologists
- American fraudsters
- People convicted of obstruction of justice
- American perjurors
- American chief executives
- American prisoners and detainees
- American white-collar criminals
- Businesspeople in the pharmaceutical industry
- Corporate crime
- Prisoners and detainees of the United States federal government
- People convicted of insider trading
- American people convicted of fraud
